CORONARY ARTERY CONSTRICTION
CORONARY ARTERY CONSTRICTION
批准号:
2210207
负责人:
Joseph A. Vita
金额:
$7.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-04-01 至 1995-03-31
关键词:
acetylcholine angiography antiadrenergic agents arginine aspirin bioassay cholesterol coronary artery coronary disorder coronary occlusion /thrombosis coronary vasodilator disease /disorder model heart catheterization human subject lovastatin miniature swine nitric oxide phenylephrine placebos ultrasound blood flow measurement vasomotion
中文摘要
最近的研究表明,动脉粥样硬化的功能异常
冠状动脉通过以下途径促进心肌缺血的产生
产生收缩和/或血栓形成。现在很明显,
血管内皮细胞在控制血管张力和
动脉粥样硬化对内皮血管扩张剂有不利影响
功能。在建议的培训期间,申请者将测试
假设血管内皮的血管运动功能紊乱
导致冠状动脉收缩反应的产生
与临床相关的刺激,这些干扰是可逆的。
血管内皮细胞依赖性松弛的前体L-精氨酸的作用
因子,EDRF)对增加的血流和输注的反应
冠心病患者将接受苯肾上腺素检查
正在接受心脏导管术的。动脉功能将通过以下方式评估
输注内皮依赖性药物并检测直径反应
多普勒血流导管的定量血管造影和血流反应。一个
建议进行安慰剂对照试验,以确定是否减少
降低血清胆固醇可以改善冠状动脉血管扩张剂
在病人身上起作用。申请人建议进一步研究这些问题
动物模型中的问题(胆固醇喂养/气球损伤的微型模型
猪)。大鼠髂动脉和冠状动脉的血管运动反应
动脉粥样硬化的血流量增加和儿茶酚胺输注将是
观察L-精氨酸、单甲基精氨酸、
D-精氨酸、亚甲蓝和特定的肾上腺素能拮抗剂。动脉
然后,节段将被切除以在器官室内进行研究,提供
有机会将这些实验方法联系起来并确定
在这些反应中,平滑肌功能障碍的重要性。这一问题
功能异常的可逆性将通过检查
同一动物在喂饲胆固醇期间和在
回归。培训期间将为以下人员提供机会
申请者作为临床调查员发展新技能和经验
在缺血性心脏病领域。申请人建议这些
研究将提供对病理机制的洞察并提出新的
冠状动脉疾病患者的治疗方法。
英文摘要
Recent studies have shown that functional abnormalities of atherosclerotic
coronary arteries contribute to the production of myocardial ischemia by
producing constriction and/or thrombus formation. It is now clear that the
vascular endothelium plays a central role in controlling vascular tone and
that atherosclerosis has an adverse effect on endothelial vasodilator
function. In the proposed training period, the applicant will test the
hypothesis that disturbance of the vasomotor function of the endothelium
contributes to the production of coronary artery constriction in response
to clinically relevant stimuli and that these disturbances are reversible.
The effect of L-arginine (the precursor of endothelium-dependent relexating
factor, EDRF) on the response to increased blood flow and infused
phenylephrine will be examined in patients with coronary artery disease
undergoing cardiac catheterization. Arterial function will be assessed by
infusing endothelium-dependent agents and examining diameter responses with
quantitative angiography and flow responses with Doppler-flow catheter. A
placebo-controlled trial is proposed that will determine whether reduction
of serum cholesterol can produce an improvement in coronary vasodilator
function in patients. The applicant proposes to further examine these
issues in an animal model (cholesterol-fed/balloon-injured miniature
swine). The vasomotor responses of the iliac and coronary arteries to
increased blood flow and infused catecholamines in atherosclerosis will be
studied before and after treatment with L-arginine, mono-methyl arginine,
D-arginine, methylene blue and specific adrenergic antagonists. Arterial
segments will then be excised for study in the organ chamber, providing an
opportunity to correlate these experimental methods and to determine the
importance of smooth muscle dysfunction in these responses. The issue of
reversibility of functional abnormalities will be studied by examining
diameter responses in the same animal during cholesterol feeding and during
regression. The period of training will provide an opportunity for the
applicant to develop new skills and experience as a clinical investigator
in the field of ischemic heart disease. The applicant proposes that these
studies will provide insight into pathologic mechanisms and suggest new
approaches for management of patients with coronary artery disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity
-
批准号:8583774
-
项目类别:
-
资助金额:$55.53万
-
财政年份:2013
-
负责人:Joseph A. Vita
-
依托单位:
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM
-
批准号:8109656
-
项目类别:
-
资助金额:$58.83万
-
财政年份:2011
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7566010
-
项目类别:
-
资助金额:$117.55万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7351857
-
项目类别:
-
资助金额:$81.03万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7767681
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Boston University Medical Center Leadership Program in Vascular Medicine
-
批准号:7066895
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2007
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7452358
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7851079
-
项目类别:
-
资助金额:$235.15万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7621045
-
项目类别:
-
资助金额:$228.82万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Administrative Core
-
批准号:7140910
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7278281
-
项目类别:
-
资助金额:$47.67万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7141989
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7066974
-
项目类别:
-
资助金额:$218.53万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Mechanisms of Vascular Dysfunction in Acute Insulin Resistance
-
批准号:7140900
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Determinants of Shear Stress-Mediated Arterial Remodeling
-
批准号:7640935
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7227535
-
项目类别:
-
资助金额:$216.23万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Vascular Consequences of Insulin Resistance and Obesity
-
批准号:7418248
-
项目类别:
-
资助金额:$218.0万
-
财政年份:2006
-
负责人:Joseph A. Vita
-
依托单位:
Mitochondrial Metabolism and Endothelial Dysfunction
-
批准号:7137205
-
项目类别:
-
资助金额:$48.17万
-
财政年份:2005
-
负责人:Joseph A. Vita
-
依托单位:
Clinical Utility of Endothelial Function in PAD
-
批准号:6942746
-
项目类别:
-
资助金额:$99.96万
-
财政年份:2003
-
负责人:Joseph A. Vita
-
依托单位:
Clinical Utility of Endothelial Function in PAD
-
批准号:6730929
-
项目类别:
-
资助金额:$99.99万
-
财政年份:2003
-
负责人:Joseph A. Vita
-
依托单位:
海外基金